A longitudinal study of plasma levels of soluble fms-like tyrosine kinase 1 (sFlt1), placental growth factor (PlGF), sFlt1: PlGF ratio and vascular endothelial growth factor (VEGF-A) in normal pregnancy

Acta Obstetricia et Gynecologica Scandinavica

Volumn 90, Issue 11, 2011, Pages 1244-1251

  Palm, Maria ^a   Basu, Samar ^b   Larsson, Anders ^a   Wernroth, Lisa ^a   Åkerud, Helena ^a   Axelsson, Ove ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Angiogenesis; placental growth factor; pregnancy; pregnancy complications; soluble fms like tyrosine kinase 11; vascular endothelium growth factor A

Indexed keywords

PLACENTAL GROWTH FACTOR; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1;

ADULT; ARTICLE; BLOOD SAMPLING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; SWEDEN;

ADULT; FEMALE; HUMANS; LONGITUDINAL STUDIES; PREGNANCY; PREGNANCY PROTEINS; REFERENCE VALUES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 80054717417     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/j.1600-0412.2011.01186.x     Document Type: Article

References (25)

1. Hanahan D, Folkman J,. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996; 86: 353-64. (Pubitemid 26272076)
2. Bdolah Y, Sukhatme VP, Karumanchi SA,. Angiogenic imbalance in the pathophysiology of preeclampsia: newer insights. Semin Nephrol. 2004; 24: 548-56. (Pubitemid 39505044)
3. Shore VH, Wang TH, Wang CL, Torry RJ, Caudle MR, Torry DS,. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta. 1997; 18: 657-65. (Pubitemid 27448423)
4. Ferrara N, Gerber HP,. The role of vascular endothelial growth factor in angiogenesis. Acta Haematol. 2001; 106: 148-56. (Pubitemid 34124153)
5. Benjamin LE, Keshet E,. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc Natl Acad Sci U S A. 1997; 94: 8761-6.
6. Clark DE, Charnock-Jones DS,. Placental angiogenesis: the role of the VEGF family of proteins. Angiogenesis. 1998; 2: 309-18. (Pubitemid 128514258)
7. Kendall RL, Thomas KA,. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci U S A. 1993; 90: 10705-9. (Pubitemid 23347111)
8. Bujold E, Romero R, Chaiworapongsa T, Kim YM, Kim GJ, Kim MR, et al,. Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin. J Matern Fetal Neonatal Med. 2005; 18: 9-16. (Pubitemid 41224357)
9. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al,. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003; 111: 649-58. (Pubitemid 36278583)
10. Romero R, Nien JK, Espinoza J, Todem D, Fu W, Chung H, et al,. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med. 2008; 21: 9-23.
11. Wikstrom AK, Larsson A, Eriksson UJ, Nash P, Norden-Lindeberg S, Olovsson M,. Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia. Obstet Gynecol. 2007; 109: 1368-74. (Pubitemid 46869876)
12. Asvold OB, Vatten LJ, Romundstad PR, Jenum PA, Karumanchi SA, Eskild A,. Angiogenic factors in maternal circulation and the risk of severe fetal growth restriction. Am J Epidemiol. 2011; 173: 630-9.
13. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, et al,. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006; 355: 992-1005. (Pubitemid 44343543)
14. Verlohren S, Galindo A, Schlembach D, Zeisler H, Herraiz I, Moertl MG, et al,. An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol. 2010; 202: 161 e1-11.
15. Torry DS, Wang HS, Wang TH, Caudle MR, Torry RJ,. Preeclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gynecol. 1998; 179: 1539-44. (Pubitemid 29028397)
16. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al,. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004; 350: 672-83. (Pubitemid 38364626)
17. Taylor RN, Grimwood J, Taylor RS, McMaster MT, Fisher SJ, North RA,. Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol. 2003; 188: 177-82. (Pubitemid 36135616)
18. Chappell LC, Seed PT, Briley A, Kelly FJ, Hunt BJ, Charnock-Jones DS, et al,. A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol. 2002; 187: 127-36. (Pubitemid 34800311)
19. Powers RW, Roberts JM, Cooper KM, Gallaher MJ, Frank MP, Harger GF, et al,. Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia. Am J Obstet Gynecol. 2005; 193: 185-91. (Pubitemid 40991843)
20. Chaiworapongsa T, Romero R, Kim YM, Kim GJ, Kim MR, Espinoza J, et al,. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia. J Matern Fetal Neonatal Med. 2005; 17: 3-18. (Pubitemid 40515938)
21. Wikstrom AK, Larsson A, Eriksson UJ, Nash P, Olovsson M,. Early postpartum changes in circulating pro- and anti-angiogenic factors in early-onset and late-onset pre-eclampsia. Acta Obstet Gynecol Scand. 2008; 87: 146-53. (Pubitemid 351171539)
22. Karumanchi SA, Lindheimer MD,. Preeclampsia pathogenesis: 'triple a rating'-autoantibodies and antiangiogenic factors. Hypertension. 2008; 51: 991-2. (Pubitemid 351398952)
23. Noori M, Donald AE, Angelakopoulou A, Hingorani AD, Williams DJ,. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Circulation. 2010; 122: 478-87.
24. Jaffe R, Jauniaux E, Hustin J,. Maternal circulation in the first-trimester human placenta-myth or reality? Am J Obstet Gynecol. 1997; 176: 695-705. (Pubitemid 27147186)
25. Larsson A, Skoldenberg E, Ericson H,. Serum and plasma levels of FGF-2 and VEGF in healthy blood donors. Angiogenesis. 2002; 5: 107-10. (Pubitemid 36076930)